Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications

Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications

Aim. Sickle cell disease has witnessed a 41.4% surge from 2000 to 2021, significantly affecting morbidity and mortality rates, particularly in children from regions with elevated under-5 mortality rates. Gut microbiota dysbiosis is increasingly recognised in SCD, exacerbating complications, particul...

Full description

Saved in:
Bibliographic Details
Main Authors: Tarimoboere Agbalalah, Doofan Bur, Ezinne JaneFrances Nwonu, Adekunle Babajide Rowaiye
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Anemia
Online Access:http://dx.doi.org/10.1155/2024/5431000
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items